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Both ESPGHAN (2010) and AAP (2012), stated that “all
preterm infants should receive human milk” for the
many short-term and long termbenefits [1,2].
All kinds of breast milk (fresh by own mother or pas-
tourized by donor) for preterm should be fortified, to
gain the recommended requirements.
In case of its absence the only alternative is repre-
sented by the formulas for preterm infants (PTF).
It is not yet definitively established the ideal PTF com-
position, particularly for ELBW infants. Table 1 shows
the main recommendations for nutrients [1-4].
A study compared the use of a soy-based formula (with
calcium, phosphorus and vitamin D), with a PTF. Infants
taking soy showed lower growth, levels of protein and
albumin [5]. ESPGHAN in 2006 concluded that soy-based
formulas should not be used in premature infants [6].
The use of hydrolyzed formulas has not shown a pre-
ventive role on cow’s milk protein allergy, it has proven
helpful in improving food tolerance (acceleration of the
intestinal transit time and faster achievement of full ent-
eral feeding), but it has a reduced nutritional value,
(especially protein intake) [7-11].
A recent study evaluated the usefulness of a thickened
formula in reducing apnea of prematurity GERD-related.
The authors conclude that these formulas are not effective
in the reduced number of apneas GERD-related [12].
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3,3 - 3,6 Protein supply needs to compensate for the accumulated protein deficit observed in almost all small preterm infants.
The quality of the provided protein may interfere with the recommended intake because the infant does not require
proteins but requires specific aminoacids. Whey predominant protein with reduced glycomacropeptide and a-






10,5 - 12 According to the relatively reduced intestinal lactase activity, the lactose content could be relatively reduced and
replaced by glucose polymers with the characteristic of maintaining the low osmolality of the formulas.
Lipids, g 4,4 - 6 In order to improve fat absorption, an important quota of fat could be given as medium-chain triglycerides with a
maximum of 30–40% of lipid content.
Calcium, mg 110 - 130 The calcium to phosphorus ratio (1,5 – 2) may be an important determinant of calcium absorption and retention.
Phosphate, mg 55 - 80
Iron, g 1,7 - 2,7 Iron is essential for brain development, and prevention of iron deficiency is important. Prophylactic enteral iron
supplementation (given as a separate iron supplement) should be started at 2 to 6 weeks of age (2–4 weeks in
extremely-low-birth- weight infants) and should be continued after discharge, at least until 6 to 12 months of age
depending on diet.
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In recent reviews post-discharge formulas does not
seem to provide benefits, especially for the heterogeneity
of the studies [3,13]. They may be useful for infants
with GA <33 weeks, particularly those <30 weeks, with
growth at discharge below the 10th percentile (the ESP-
GHAN recommended their use up to 40 weeks, and for
a further 12 weeks if necessary) [3].
Studies about GOS and FOS showed an increase of
bifidobacteria in the stool, a reduction in their viscosity
and an acceleration of intestinal transit time, resulting
in an easier achievement of full enteral feeding [14,15].
It is also assumed a role in the prevention of NEC and
LOS. Even though they have proven their beneficial
role, further studies are needed to establish the type and
dose [16].
Several RCTs and recent reviews have shown a benefit
of prebiotics in reducing NEC andin the achievement of
full enteral feeding [17-19]. Further studies are needed to
establish dose, strains and routes of administration [1].
Lactoferrin, both human and bovine, seems to have a
significant role as a protective agent against NEC and
LOS [20-23].
The available data do not allow to recommend for-
mula supplementation with these substances with func-
tional properties.
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